PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $882,202 | +44.2% | 143,681 | +47.0% | 0.00% | – |
| Q2 2023 | $611,721 | +43.1% | 97,719 | +9.0% | 0.00% | – |
| Q1 2023 | $427,601 | -82.7% | 89,644 | -68.5% | 0.00% | -100.0% |
| Q4 2022 | $2,474,176 | +73.5% | 284,388 | +137.3% | 0.00% | 0.0% |
| Q3 2022 | $1,426,000 | -71.4% | 119,845 | -65.8% | 0.00% | -50.0% |
| Q2 2022 | $4,992,000 | +26.9% | 350,310 | +85.3% | 0.00% | +100.0% |
| Q1 2022 | $3,935,000 | +32.2% | 189,011 | +46.6% | 0.00% | 0.0% |
| Q4 2021 | $2,977,000 | +4.0% | 128,907 | +34.2% | 0.00% | 0.0% |
| Q3 2021 | $2,862,000 | +7635.1% | 96,038 | +8776.0% | 0.00% | – |
| Q2 2021 | $37,000 | -91.3% | 1,082 | -91.6% | 0.00% | – |
| Q1 2021 | $426,000 | +174.8% | 12,939 | +412.2% | 0.00% | – |
| Q4 2020 | $155,000 | +675.0% | 2,526 | +342.4% | 0.00% | – |
| Q3 2020 | $20,000 | – | 571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |